Related Experiment Video
Updated: Jul 21, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
PARP14 is a writer, reader, and eraser of mono-ADP-ribosylation
Archimede Torretta1, Constantinos Chatzicharalampous1, Carmen Ebenwaldner1
1Department of Chemistry, Center for Molecular Protein Science (CMPS), Lund University, Lund, Sweden.
Abstract:
PARP14/BAL2 is a large multidomain enzyme involved in signaling pathways with relevance to cancer, inflammation, and infection. Inhibition of its mono-ADP-ribosylating PARP homology domain and its three ADP-ribosyl binding macro domains has been regarded as a potential means of therapeutic intervention. Macrodomains-2 and -3 are known to stably bind to ADP-ribosylated target proteins, but the function of macrodomain-1 has remained somewhat elusive. Here, we used biochemical assays of ADP-ribosylation levels to characterize PARP14 macrodomain-1 and the homologous macrodomain-1 of PARP9. Our results show that both macrodomains display an ADP-ribosyl glycohydrolase activity that is not directed toward specific protein side chains. PARP14 macrodomain-1 is unable to degrade poly(ADP-ribose), the enzymatic product of PARP1. The F926A mutation of PARP14 and the F244A mutation of PARP9 strongly reduced ADP-ribosyl glycohydrolase activity of the respective macrodomains, suggesting mechanistic homology to the Mac1 domain of the SARS-CoV-2 Nsp3 protein. This study adds two new enzymes to the previously known six human ADP-ribosyl glycohydrolases. Our results have key implications for how PARP14 and PARP9 will be studied and how their functions will be understood.
Insights
Researchers characterized PARP14 macrodomain-1 and found it has ADP-ribosyl glycohydrolase activity, similar to PARP9. This discovery impacts understanding of PARP14 and PARP9 roles in disease and therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Poly(ADP-ribose) polymerases (PARPs) are crucial enzymes in DNA repair and signaling.
- PARP14/BAL2 is implicated in cancer, inflammation, and infection, with its domains targeted for therapy.
- The function of PARP14 macrodomain-1 (MD1) was previously unclear, unlike MD2 and MD3.
Purpose of the Study:
- To biochemically characterize the enzymatic activity of PARP14 MD1.
- To investigate the homologous macrodomain-1 of PARP9.
- To elucidate the functional role of these macrodomains in ADP-ribosylation.
Main Methods:
- Biochemical assays measuring ADP-ribosylation levels.
- Characterization of PARP14 MD1 and PARP9 MD1 activities.
- Site-directed mutagenesis (F926A in PARP14, F244A in PARP9) to assess activity.
Main Results:
- Both PARP14 MD1 and PARP9 MD1 exhibit ADP-ribosyl glycohydrolase activity.
- This activity is not specific to protein side chains.
- PARP14 MD1 does not degrade poly(ADP-ribose).
- Mutations F926A (PARP14) and F244A (PARP9) significantly reduced glycohydrolase activity, indicating mechanistic similarity to SARS-CoV-2 Nsp3 Mac1.
Conclusions:
- PARP14 MD1 and PARP9 MD1 are identified as novel human ADP-ribosyl glycohydrolases.
- This finding adds to the known repertoire of human glycohydrolases.
- The results necessitate a re-evaluation of how PARP14 and PARP9 functions are studied and understood in biological pathways and disease.
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer...
RNA Editing
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
RNA Polymerase II Accessory Proteins

